Analysis of information sources in references of the Wikipedia article "Hücre sinyalizasyonu" in Turkish language version.
We have shown interleukin (IL)-6 to be an important tumour promoter in early colitis-associated cancer (CAC).
Activation of JNKs (mainly JNK1) in insulin target cells results in phosphorylation of insulin receptor substrates (IRSs) at serine and threonine residues that inhibit insulin signaling.
We have shown interleukin (IL)-6 to be an important tumour promoter in early colitis-associated cancer (CAC).
Activation of JNKs (mainly JNK1) in insulin target cells results in phosphorylation of insulin receptor substrates (IRSs) at serine and threonine residues that inhibit insulin signaling.